tiprankstipranks
Trending News
More News >
SelectQuote Inc (SLQT)
:SLQT

SelectQuote (SLQT) AI Stock Analysis

Compare
366 Followers

Top Page

SL

SelectQuote

(NYSE:SLQT)

61Neutral
SelectQuote's overall stock score is supported by strong revenue growth and strategic capital investments, but is hindered by ongoing profitability challenges and technical weaknesses. The company's raised guidance and improved operational metrics are promising, yet valuation concerns and negative momentum impact the score.

SelectQuote (SLQT) vs. S&P 500 (SPY)

SelectQuote Business Overview & Revenue Model

Company DescriptionSelectQuote, Inc. is a financial services company that specializes in providing a platform for consumers to compare and purchase insurance products. Founded in 1985, the company operates in the insurance sector, offering a range of services primarily focused on life, auto, and home insurance. SelectQuote partners with various insurance carriers to provide a marketplace where customers can compare quotes and select the best insurance products that fit their needs.
How the Company Makes MoneySelectQuote makes money primarily through the commissions it receives from insurance carriers when consumers purchase insurance policies via its platform. The company operates as a brokerage, facilitating the connection between consumers and insurance providers. It earns revenue by charging these carriers a commission on every policy sold. Additionally, SelectQuote may generate income through lead generation fees from insurance carriers and fees for providing additional services, such as policy management and consulting. Key factors contributing to its earnings include the volume of insurance policies sold, the diversity of its insurance carrier partnerships, and the effectiveness of its marketing strategies in attracting consumers to its platform.

SelectQuote Financial Statement Overview

Summary
SelectQuote demonstrates strong revenue growth and improving operational margins, yet faces challenges with net profitability and equity returns. The balance sheet is stable but shows signs of increasing leverage. The positive shift in cash flow is a favorable development, though further improvements in cash efficiency are needed.
Income Statement
65
Positive
SelectQuote's income statement shows a steady revenue growth trend over the recent periods, with a noticeable increase from $764 million in 2022 to $1.46 billion in the TTM (Trailing-Twelve-Months). The gross profit margin is healthy, reaching approximately 53.9% in the TTM. However, the company is struggling with profitability at the net level, as indicated by a negative net profit margin of -0.95% in the TTM, though it shows improvement from previous years. The EBIT and EBITDA margins are positive, signaling operational efficiency improvement.
Balance Sheet
60
Neutral
The balance sheet reflects a moderate financial position with a debt-to-equity ratio of 0.17 in the TTM, indicating manageable leverage. The equity ratio stands at 25.5%, which is reasonable but shows a declining trend from previous years, suggesting increasing liabilities. Return on equity is negative due to net losses, highlighting a challenge in generating returns for shareholders.
Cash Flow
58
Neutral
SelectQuote's cash flow statement reveals a positive operating cash flow in the TTM, signaling improvement from prior periods. Free cash flow has also turned positive, indicating better cash management. However, the free cash flow to net income ratio suggests inefficiency as the company is not yet converting its earnings into cash effectively.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
1.46B1.32B1.00B764.04M937.82M531.51M
Gross Profit
784.87M597.97M475.36M297.24M667.10M364.12M
EBIT
93.96M64.55M11.58M-301.41M200.07M132.33M
EBITDA
108.05M89.48M29.91M-320.65M204.26M139.92M
Net Income Common Stockholders
-13.78M-34.13M-58.54M-297.50M124.86M79.48M
Balance SheetCash, Cash Equivalents and Short-Term Investments
12.10M42.69M83.16M141.00M286.45M321.06M
Total Assets
1.28B1.19B1.22B1.29B1.43B1.07B
Total Debt
56.10M713.92M731.58M744.80M502.72M311.81M
Net Debt
43.99M671.23M648.42M603.80M216.27M-9.25M
Total Liabilities
953.16M877.11M872.28M898.95M758.98M528.10M
Stockholders Equity
326.00M316.80M346.97M391.11M674.89M545.69M
Cash FlowFree Cash Flow
11.94M3.57M-28.50M-372.96M-138.43M-77.33M
Operating Cash Flow
18.40M15.24M-19.38M-338.31M-115.44M-61.78M
Investing Cash Flow
-14.00M-14.85M-9.13M-42.58M-64.02M-51.37M
Financing Cash Flow
-1.61M-40.86M-29.34M235.43M97.04M481.45M

SelectQuote Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.21
Price Trends
50DMA
3.92
Negative
100DMA
3.80
Negative
200DMA
3.33
Negative
Market Momentum
MACD
-0.18
Negative
RSI
44.40
Neutral
STOCH
37.49
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SLQT, the sentiment is Negative. The current price of 3.21 is below the 20-day moving average (MA) of 3.27, below the 50-day MA of 3.92, and below the 200-day MA of 3.33, indicating a bearish trend. The MACD of -0.18 indicates Negative momentum. The RSI at 44.40 is Neutral, neither overbought nor oversold. The STOCH value of 37.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SLQT.

SelectQuote Risk Analysis

SelectQuote disclosed 54 risk factors in its most recent earnings report. SelectQuote reported the most risks in the “Production” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

SelectQuote Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$737.87M9.1719.28%-2.78%24.39%
73
Outperform
$815.24M10.888.93%2.95%7.17%12.20%
72
Outperform
$655.05M12.1913.11%3.70%5.29%1200.44%
63
Neutral
$12.06B9.318.10%79.51%12.80%-4.67%
61
Neutral
$568.08M-4.16%25.67%72.08%
56
Neutral
$596.28M-35.80%33.86%66.85%
LDLDI
48
Neutral
$367.68M-31.41%3.76%16.19%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SLQT
SelectQuote
3.30
1.75
112.90%
DGICA
Donegal Group
19.55
6.35
48.11%
TREE
Lendingtree
51.53
15.10
41.45%
UVSP
Univest Of Pennsylvania
29.39
9.49
47.69%
WRLD
World Acceptance
135.70
-1.31
-0.96%
LDI
loanDepot
1.09
-1.25
-53.42%

SelectQuote Earnings Call Summary

Earnings Call Date: Feb 10, 2025 | % Change Since: -26.71% | Next Earnings Date: May 8, 2025
Earnings Call Sentiment Positive
The earnings call reflects a strong performance overall, with significant revenue and EBITDA growth, successful Medicare Advantage and SelectRx results, and strategic capital structure improvements. The raised guidance indicates confidence in continued robust performance. However, challenges from increased Medicare Advantage plan terminations and anticipated moderation in SelectRx growth present areas of concern.
Highlights
Revenue and EBITDA Growth
SelectQuote reported a 19% increase in revenue, reaching $481 million, and a 30% increase in adjusted EBITDA, totaling $88 million compared to the previous year.
Medicare Advantage Performance
The Senior division delivered robust results with Medicare Advantage policy volume growing by 6%, impressive agent productivity, and a 39% adjusted EBITDA margin, up from 32% the previous year.
SelectRx Membership Expansion
SelectRx membership grew by 54% year-over-year, with revenues reaching $183 million, representing a 64% increase. The segment concluded with an annual run rate exceeding $700 million.
Capital Structure Improvement
SelectQuote secured a $350 million preferred equity offering led by Bain Capital and others, to improve capital structure. This move is expected to decrease ongoing capital costs by over 150 basis points and reduce annual cash interest obligations by approximately $30 million.
Guidance Increase
The company raised its fiscal 2025 guidance ranges for revenue, adjusted EBITDA, and net income, expecting revenue between $1.5 billion and $1.575 billion, and adjusted EBITDA between $115 million and $140 million.
Lowlights
Medicare Advantage Plan Terminations
Carrier terminations reached 6% this season, which is about fifteen times higher than normal. Although SelectQuote recaptured over 30%, the net cash impact from terminated and recaptured plans was estimated at around $5 million.
Moderation in SelectRx Growth
SelectRx membership growth is expected to moderate in the second half of the fiscal year, despite earlier successes in converting AEP enrollees to members.
Company Guidance
During SelectQuote's fiscal second quarter 2025 earnings call, the company raised its guidance for the year, highlighting impressive performance metrics across its segments. SelectQuote reported a 19% year-over-year revenue growth, reaching $481 million, with Medicare Advantage policy volume increasing by 6% despite a 22% reduction in agent headcount. This efficiency led to a 39% adjusted EBITDA margin in the senior segment, up from 32% the previous year. The company's revenue to customer acquisition cost (CAC) ratio improved to 5.3x, underscoring scale advantages. Additionally, SelectRx membership grew by 54%, contributing to a 64% revenue increase in the health care services segment. The guidance for fiscal 2025 was raised, with expected revenue between $1.5 billion to $1.575 billion and adjusted EBITDA between $115 million to $140 million, reflecting the strong operational performance and strategic capital structure enhancements, including a $350 million preferred equity offering.

SelectQuote Corporate Events

Executive/Board ChangesPrivate Placements and FinancingDividends
SelectQuote Secures $350 Million Investment from NL Monarch
Positive
Feb 28, 2025

On February 28, 2025, SelectQuote, Inc. completed the sale of 350,000 shares of Senior Non-Convertible Preferred Stock and 30,833,333 warrants to purchase common stock to NL Monarch Holdings LLC and NL Monarch Holdings II LLC, marking a significant $350 million investment. This transaction is expected to impact SelectQuote’s financial structure and operations, with implications for stakeholders, including changes in board composition and potential adjustments in dividend rates based on company liquidity and financial performance.

Private Placements and FinancingFinancial Disclosures
SelectQuote Secures $350 Million Investment to Boost Liquidity
Positive
Feb 10, 2025

On February 10, 2025, SelectQuote, Inc. entered into Senior Preferred Stock Purchase Agreements with Morgan Stanley and Bain, resulting in a $350 million investment in the company. This investment aims to improve SelectQuote’s liquidity and operating flexibility, particularly in its Senior and Healthcare Services segments. The transaction includes the issuance of preferred stock and warrants. Additionally, the company reported strong financial results for the second quarter of fiscal year 2025, with increased revenue and net income compared to the previous year, driven by strong performance in its Senior and Healthcare Services segments.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.